武汉大学人民医院湖北省人民医院

院内导航

江万里 心胸外
教学秘书，副教授，副主任医师，硕士生导师

A+ A-

导师介绍

姓名	江万里
出生年月	1988年12月
单位	武汉大学人民医院胸外科
所属学科	临床医学-外科学
职务、职称及头衔	教学秘书，副教授，副主任医师，硕士生导师
E-mail	Jiang.wanli@qq.com
联系方式	027-88041911转82240或18627806783
研究方向	急性肺损伤及胸部肿瘤疾病的发病机制研究及临床防治
个人简介	主要从事胸外科疾病的诊治与科研工作，以项目负责人主持国家自然科学基金青年项目一项，国家自然科学基金面上项目一项；湖北省自然科学基金青年项目一项，省自然科学基金面上项目一项，拥有国家级发明专利一项。以第一或通讯作者在SCI收录期刊上发表论文近20篇，其中一区期刊6篇，最高影响因子为IF=11.4。已协助培养硕士生7名，博士生10名。
学术任职与荣誉	湖北省微循环学会胸部微创外科青年委员会常委；湖北省临床肿瘤学会肺癌专家委员会委员；湖北省生物医学工程学会委员；中国老年学和老年医学学会肿瘤康复分会委员
教育履历	2007.09-2012.06天津医科大学临床医学专业本科生获学士学位 2012.09-2015.06武汉大学第一临床学院外科学硕士研究生获硕士学位 2015.09-2018.06武汉大学第一临床学院外科学博士研究生获博士学位
工作履历	2017.03-2018.03 美国Ohio State University联合培养，访问学者 2018.07-2020.10 武汉大学人民医院胸外科主治医师 2020.11-至今武汉大学人民医院胸外科副教授、副主任医师
成果获奖	1. 2022年武汉大学人民医院医疗菁英 2.2020年《肺移植缺血再灌注损伤机制及临床关键技术创新》获湖北省科技进步奖一等奖 3.2020年湖北省卫健委优秀青年人才 4.2019年度“武汉黄鹤英才”优秀青年人才奖；
代表性论著	1．Jiang W, Ma C, Bai J, Du X. Macrophage SAMSN1 protects against sepsis-induced acute lung injury in mice. Redox Biol. 2022 Oct;56:102432.. 2．Jiang W, Li W, Hu X, Hu R, Li B, Lan L. CTRP1 prevents sepsis-induced cardiomyopathy via Sirt1-dependent pathways. Free Radic Biol Med. 2020 May 20;152:810-820. 3．Lu QB, Jiang WL, Zhang X, Li HJ, Zhang XA, Zeng HL, Du J, Yang GL, Zhang LK, Li R, Fang LQ, Li H, Liu W. Comorbidities for fatal outcome among the COVID-19 patients: A hospital-based case-control study. J Infect. 2021 Jan;82(1):159-198. 4. Jiang WL, Zhao KC, Yuan W, Zhou F, Song HY, Liu GL, Huang J, Zou JJ, Zhao B, Xie SP. MicroRNA-31-5p Exacerbates Lipopolysaccharide-Induced Acute Lung Injury via Inactivating Cab39/AMPKα Pathway. Oxid Med Cell Longev. 2020 Oct 8;2020:8822361. 5. Xie S, Liu G, Huang J, Hu HB, Jiang W. miR-210 promotes lung adenocarcinoma proliferation, migration, and invasion by targeting lysyl oxidase-like 4. J Cell Physiol. 2019 Aug;234(8):14050-14057. 6．Zhang Y, Jiang WL, Yang JY, Huang J, Kang G, Hu HB, Xie S. Downregulation of lysyl oxidase-like 4 LOXL4 by miR-135a-5p promotes lung cancer progression in vitro and in vivo. J Cell Physiol. 2019 Aug;234(10):18679-18687. 7．Tang Z, Jiang W, Mao M, Zhao J, Chen J, Cheng N. Deubiquitinase USP35 modulates ferroptosis in lung cancer via targeting ferroportin. Clin Transl Med. 2021 Apr;11(4):e390. 8. Zeng Z, Xu L, Xie XY, Yan HL, Xie BJ, Xu WZ, Liu XA, Kang GJ, Jiang WL, Yuan JP. Pulmonary pathology of early-phase COVID-19 pneumonia in a patient with a benign lung lesion. Histopathology. 2020 Nov;77(5):823-831.

Name	JIANG WANLI
Date of birth	December，1988
Department	Department of thoracic surgery，Renmin Hospital,Wuhan University.
Title	associate chief physician, associate Professor, master tutor
Email	Jiang.wanli@qq.com
TEL	027-88041911-82240 or 18627806783
Research Direction	Study on the pathogenesis and clinical prevention and treatment of acute lung injury and chest tumor diseases
Personal Profile	He is mainly engaged in the diagnosis, treatment, and scientific research of thoracic surgery diseases, led by the project leader to lead a youth project of the National Natural Science Foundation of China and a general project of the National Natural Science Foundation of China; One youth project of the Hubei Provincial Natural Science Foundation, one general project of the Provincial Natural Science Foundation, and one national invention patent. Published nearly 20 papers as the first or corresponding author in SCI indexed journals, including 6 journals in the first region, with the highest impact factor of IF=11.4. We have assisted in cultivating 7 master's and 10 doctoral students.
Selected Publications	1． Jiang W, Ma C, Bai J, Du X. Macrophage SAMSN1 protects against sepsis-induced acute lung injury in mice. Redox Biol. 2022 Oct;56:102432.. 2．Jiang W, Li W, Hu X, Hu R, Li B, Lan L. CTRP1 prevents sepsis-induced cardiomyopathy via Sirt1-dependent pathways. Free Radic Biol Med. 2020 May 20;152:810-820. 3．Lu QB, Jiang WL, Zhang X, Li HJ, Zhang XA, Zeng HL, Du J, Yang GL, Zhang LK, Li R, Fang LQ, Li H, Liu W. Comorbidities for fatal outcome among the COVID-19 patients: A hospital-based case-control study. J Infect. 2021 Jan;82(1):159-198. 4. Jiang WL, Zhao KC, Yuan W, Zhou F, Song HY, Liu GL, Huang J, Zou JJ, Zhao B, Xie SP. MicroRNA-31-5p Exacerbates Lipopolysaccharide-Induced Acute Lung Injury via Inactivating Cab39/AMPKα Pathway. Oxid Med Cell Longev. 2020 Oct 8;2020:8822361. 5. Xie S, Liu G, Huang J, Hu HB, Jiang W. miR-210 promotes lung adenocarcinoma proliferation, migration, and invasion by targeting lysyl oxidase-like 4. J Cell Physiol. 2019 Aug;234(8):14050-14057. 6． Zhang Y, Jiang WL, Yang JY, Huang J, Kang G, Hu HB, Xie S. Downregulation of lysyl oxidase-like 4 LOXL4 by miR-135a-5p promotes lung cancer progression in vitro and in vivo. J Cell Physiol. 2019 Aug;234(10):18679-18687. 7． Tang Z, Jiang W, Mao M, Zhao J, Chen J, Cheng N. Deubiquitinase USP35 modulates ferroptosis in lung cancer via targeting ferroportin. Clin Transl Med. 2021 Apr;11(4):e390. 8. Zeng Z, Xu L, Xie XY, Yan HL, Xie BJ, Xu WZ, Liu XA, Kang GJ, Jiang WL, Yuan JP. Pulmonary pathology of early-phase COVID-19 pneumonia in a patient with a benign lung lesion. Histopathology. 2020 Nov;77(5):823-831.